Four versions of generic Loestrin are currently available: Gildess, Junel, Larin, and Microgestin. Although the FDA has determined that generic Loestrin is equivalent to the brand-name drug, it's important to know that the generic versions may contain different inactive ingredients, which may cause problems for people with allergies or sensitivities.
Is Generic Loestrin Available?
Loestrin® (norethindrone/ethinyl estradiol) is one of the many oral contraceptives (birth control pills) available. It belongs to a group of medications known as combined oral contraceptives, named because they contain a combination of two different types of hormones. Also, it is a monophasic birth control pill (as opposed to a biphasic or triphasic pill), because the strength of the pills does not vary throughout the cycle.
(Loestrin is not the same as Loestrin® Fe or Loestrin® 24 Fe. The information in this article does not apply to either of these medications.)
Currently, Loestrin is made by Duramed Pharmaceuticals, Inc., although it was first made by Warner Chilcott Company, Inc. Generic Loestrin is available; however, it is sold under what looks like other brand names, rather than the usual generic name.
Names for Generic Loestrin
Generic Loestrin is sold under the following names:
The generic names of birth control pills can be confusing; the names are long, and several different products can have the same generic name, even though they are different. To avoid confusion, manufacturers of generic birth control pills give their versions a "brand name," instead of using the standard generic name. These products are still generics, even though they seem like brand-name products, due to their names.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Junel/Junel Fe [package insert]. Pomona, NY: Barr Pharmaceuticals, Inc.;2005 May.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 2, 2014.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click